LMS closes $2.0 million private placement

    MONTREAL, March 6 /CNW Telbec/ - LMS Medical Systems (AMEX:  LMZ; TSX:LMZ),
a healthcare technology company and developer of the CALM(TM) clinical
information system and risk management software for obstetrics, today
announced that it has closed a $2.0 million private placement.
    The private placement comprised 4 million units at a purchase price of
$0.50 per unit which generated $2 million in gross proceeds prior to the
deduction of placement agent fees and offering related expenses. Each unit is
comprised of one common share and a quarter warrant, each full warrant being
exercisable for one common share at a strike price of $0.60 for a period of
five years from the date of issue. Proceeds from the financing will be used
for general working capital and for sales and marketing activities.

    About LMS: LMS is a leader in the application of advanced mathematical
modeling and neural networks for medical use. The LMS CALM Decision Support
Suite provides physicians, nursing staff, risk managers and hospital
administrators with clinical information systems and risk management tools
designed to improve outcomes and patient care for mothers and their infants
during childbirth.

    Except for historical information contained herein, the matters discussed
in this news release are forward-looking statements. Because these
forward-looking statements involve risks and uncertainties, there are
important factors that could cause actual results to differ materially from
those expressed implied by the forward-looking statements including, but
without limitation, economic conditions in general and in the healthcare
market, the demand for and market for our products in domestic and
international markets, our current dependence on the CALM product suite, the
challenges associated with developing new products and obtaining regulatory
approvals if necessary, research and development activities, the uncertainty
of acceptance of our products by the medical community, the lengthy sales
cycle for our products, third party reimbursement, competition in our markets,
including the potential introduction of competitive products by others, our
dependence on our distributors, physician training, enforceability and the
costs of enforcement of our patents, potential infringements of our patents
and the other factors set forth from time to time in the Company's filings
with the United States Securities and Exchange Commission and with the
Canadian Securities Commissions. The Company has no intention of or obligation
to update or revise any forward-looking statements, whether as a result of new
information, future events or otherwise.

For further information:

For further information: about LMS Medical Systems: Yves Grou, Chief
Financial Officer, LMS Medical Systems Inc., (514) 488-3461 Ext. 238, Fax:
(514) 488-1880, yves.grou@lmsmedical.com, www.lmsmedical.com

Organization Profile


More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890